Health Canada drug identification number

DIN 02556219 — SKYCLARYS 50 MG

SKYCLARYS is a capsule of Omaveloxolone marketed by BIOGEN CANADA INC. The full Omaveloxolone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02556219
Brand name
SKYCLARYS
Active ingredient
Omaveloxolone
Strength
50 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
BIOGEN CANADA INC
Health Canada status
MARKETED
Drug class
Nrf2 activator (nervous system agent) for Friedreich's ataxia

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.